Earnings Feed
Start Free
|4Jan 4, 8:05 PM ET

BIOJECT MEDICAL TECHNOLOGIES INC 4

4 · BIOJECT MEDICAL TECHNOLOGIES INC · Filed Jan 4, 2011

Insider Transaction Report

Form 4
Period: 2010-12-31
BIOJECT MEDICAL TECHNOLOGIES INCBJCT
FARRELL CHRISTINE
VP of Finance
Transactions
  • Exercise/Conversion

    BJCT Common Stock

    2010-12-31+39,000→ 293,024 total
  • Exercise/Conversion

    Restricted Stock Unit

    2010-12-31−39,000→ 461,421 total
    From: 2010-12-31→ BJCT Common Stock (39,000 underlying)
Holdings

  • BJCT Common Stock

    (indirect: By 401(k))
    110,274
Footnotes (4)
  • [F1]Vesting of 3,500 Restricted Stock Unit shares awarded 12/7/06, 10,500 Restricted Stock Unit shares awarded 6/14/07 and 25,000 Restricted Stock Unit shares awarded 6/25/08.
  • [F2]No expiration date.
  • [F3]Each Restricted Stock Unit represents a contingent right to receive one share of BJCT Common Stock.
  • [F4]Includes Series F Preferred Stock 10,100, Warrant (right-to-buy) 1,000, Option (right-to-buy) 425,321 Restricted Stock Unit 25,000.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT